drugset / Trial / NCT05683561
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of SCTV01E in Healthy People
RandomizedParallel-groupTriple-blindPrevention
Summary
The objective of this study is to evaluate the effectiveness of SCTV01E in healthy people
Timeline
- Start
- 2023-01-25
- Primary completion
- 2023-08-25
- Completion
- 2024-08-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CoronaVac | Vaccine | — | Intramuscular |
| Subject | SCTV01E | Vaccine | — | Intramuscular |